An update from Pharmaust Limited ( (AU:NUZ)) is now available. Neurizon Therapeutics has provided a regulatory update on NUZ-001, its investigational ALS therapy, confirming that the US FDA has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results